Literature DB >> 10074432

A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells.

Z Zhang1, C Elly, L Qiu, A Altman, Y C Liu.   

Abstract

Engagement of the T-cell receptor (TCR)-CD3 complex induces a rapid increase in the activities of Src-family and Syk/Zap-70-family kinases [1] [2]. These activated kinases then induce the tyrosine phosphorylation of multiple intracellular proteins, eventually leading to T-cell activation. One of the prominent substrates for these kinases is the adaptor protein Cbl [3] and recent studies suggest that Cbl negatively regulates upstream kinases such as Syk and Zap-70 [4] [5]. Cbl-b, a homologue of Cbl, is widely expressed in many tissues and cells including hematopoietic cells [6] [7]. Cbl-b undergoes rapid tyrosine phosphorylation upon stimulation of the TCR and cytokine receptors [8] [9]. The role of Cbl-b is unclear, however. Here, we show that overexpression of Cbl-b in T cells induced the constitutive activation of the transcription factor nuclear factor of activated T cells (NFAT). A loss-of-function mutation in Cbl-b disrupted the interaction between Cbl-b and Zap-70 and nearly completely abrogated the Cbl-b-mediated activation of NFAT. Unlike the proposed role of Cbl as a negative regulator, our results suggest that the Cbl homologue Cbl-b has a positive role in T-cell signaling, most likely via a direct interaction with the upstream kinase Zap-70.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074432     DOI: 10.1016/s0960-9822(99)80090-6

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  13 in total

1.  Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion.

Authors:  T M Fournier; L Lamorte; C R Maroun; M Lupher; H Band; W Langdon; M Park
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia.

Authors:  Liguang Chen; Lang Huynh; John Apgar; Li Tang; Laura Rassenti; Arthur Weiss; Thomas J Kipps
Journal:  Blood       Date:  2007-11-29       Impact factor: 22.113

3.  Identifying mutation specific cancer pathways using a structurally resolved protein interaction network.

Authors:  H Billur Engin; Matan Hofree; Hannah Carter
Journal:  Pac Symp Biocomput       Date:  2015

4.  Cbl-b is a novel physiologic regulator of glycoprotein VI-dependent platelet activation.

Authors:  James L Daniel; Carol A Dangelmaier; Sripal Mada; Lorena Buitrago; Jianguo Jin; Wallace Y Langdon; Alexander Y Tsygankov; Satya P Kunapuli; Archana Sanjay
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

5.  Phosphotyrosine-dependent interaction between the kinases PKCθ and Zap70 promotes proximal TCR signaling.

Authors:  Jiji Xie; Xuemei Han; Chensi Zhao; Ann J Canonigo-Balancio; John R Yates; Yingqiu Li; Björn F Lillemeier; Amnon Altman
Journal:  Sci Signal       Date:  2019-04-16       Impact factor: 8.192

6.  Cbl-3-deficient mice exhibit normal epithelial development.

Authors:  Emily K Griffiths; Otto Sanchez; Pleasantine Mill; Connie Krawczyk; Carlo V Hojilla; Evelyn Rubin; Marion M Nau; Rama Khokha; Stan Lipkowitz; Chi-Chung Hui; Josef M Penninger
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

Review 7.  E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.

Authors:  Qingjun Liu; Hong Zhou; Wallace Y Langdon; Jian Zhang
Journal:  Cell Cycle       Date:  2014-05-14       Impact factor: 4.534

8.  T cell development and T cell responses in mice with mutations affecting tyrosines 292 or 315 of the ZAP-70 protein tyrosine kinase.

Authors:  A Magnan; V Di Bartolo; A M Mura; C Boyer; M Richelme; Y L Lin; A Roure; A Gillet; C Arrieumerlou; O Acuto; B Malissen; M Malissen
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

9.  E3 ubiquitin ligase Cbl-b negatively regulates C-type lectin receptor-mediated antifungal innate immunity.

Authors:  Le-Le Zhu; Tian-Ming Luo; Xia Xu; Ya-Hui Guo; Xue-Qiang Zhao; Ting-Ting Wang; Bing Tang; Yuan-Ying Jiang; Jin-Fu Xu; Xin Lin; Xin-Ming Jia
Journal:  J Exp Med       Date:  2016-07-18       Impact factor: 14.307

10.  Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells.

Authors:  Tomoharu Yasuda; Tohru Tezuka; Akito Maeda; Tetsuya Inazu; Yuji Yamanashi; Hua Gu; Tomohiro Kurosaki; Tadashi Yamamoto
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.